Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SXTCSXTC
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in China SXT Pharmaceuticals, Inc.

CITADEL ADVISORS LLC previously held 0 shares of SXTC (China SXT Pharmaceuticals, Inc.), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$77,527

Total Shares Change

-48,759

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.68
0
2025-Q4
Increased
150,576
+208.8%
$240,9220.0%$240.00
25
2025-Q3
New
48,759
-
$77,5270.0%$235.50
33

Other major holders of SXTC: Invesco Ltd., UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used